Share
CytoSorb® is CE-mark approved in the E.U. In the U.S., CytoSorb® and DrugSorb-ATR® are investigational devices not yet FDA authorized/approved/cleared.

The new CytoSorb exchange system

*Not authorized / cleared / approved for human use in the USA

 

CE-marked

Hemoadsorption procedures frequently require multiple adsorber cartridges according to treatment protocols and clinical assessment.

 

The ability to streamline adsorber cartridge exchanges is expected to limit additional logistical considerations for extracorporeal circuit management.

 

In collaboration with healthcare professionals, CytoSorbents has developed a pre-assembled blood line system to support structured and efficient adsorber cartridge exchanges in CRRT and hemoperfusion setups.

 

HotSwap® is CE-marked for use by trained healthcare professionals in extracorporeal blood purification procedures, in accordance with the Instructions for Use.

Features

Simple integration into CRRT and Hemoperfusion (HP) platforms
Intelligent design with bypass and adsorber lines readily supporting alternating blood flow
Approved for continuous 96 hour use

HotSwap® may be used in extracorporeal blood purification procedures where replacement of more than one adsorber cartridge is anticipated.

Consider use of HotSwap in clinical settings where:

CytoSorb therapy frequently requires multiple adsorber cartridge changes
Hotswap technology supports early initiation and seamless CytoSorb therapy
Critical patients frequently require prolonged support with multiple adsorbers
  • CytoSorb therapy frequently requires multiple adsorber cartridge changes
  • Hotswap technology supports early initiation and seamless CytoSorb therapy
  • Critical patients frequently require prolonged support with multiple adsorbers
Mode of Use

HotSwap is intended for a duration of use of up to 96 hours

Key advantages of HotSwap for your daily practice

Safety

  • No catheter manipulation
  • Improved patient interface
  • Simpler blood conservation

 

Flexibility

  • Multiple adsorber changes
  • Versatile Integration into extracorporeal circuits (EC)
  • Flexible replacement scheme
Convenience

  • Time saving workflow
  • Intuitive handling steps
  • Seamless circuit integration

Contact us to discover more
about HotSwap™

HotSwap at a glance

Additional Information

HotSwap IFU Intended Use:
 
The Hot-Swap System (HSS) is intended for integration of a CytoSorbents whole blood adsorber into extracorporeal (EC) circuits such as continuous renal replacement therapy (CRRT), hemoperfusion (HP), hemodialysis (HD), or hemofiltration (HF).
 
The HSS is integrated into the EC bloodline during priming.
 
After circuit setup, the CytoSorb adsorber may be connected, exchanged, or removed as clinically required without interrupting EC blood flow.
 
The system allows separate flushing of line segments to support circuit management and help reduce clotting risk.
 
The accessory is intended for use by trained healthcare professionals only.
The HSS is intended to remain in the EC circuit for the typical operating time of the host system (maximum 96 hours).